142 related articles for article (PubMed ID: 38252069)
1. Trends and Disparities in Curative-Intent Treatment for Early-Stage Non-Small Cell Lung Cancer: A Population-Based Analysis of Surgery and SBRT.
Liu Q; Medina HN; Rodriguez E; Jacobs KT; Brown C; Koru-Sengul T; Lopes G; Pinheiro PS
Cancer Epidemiol Biomarkers Prev; 2024 Apr; 33(4):489-499. PubMed ID: 38252069
[TBL] [Abstract][Full Text] [Related]
2. Racial Disparities in Early-Stage NSCLC Treatment: A Call for Action.
Pellini B; Chaudhuri AA
Cancer Epidemiol Biomarkers Prev; 2024 Jun; 33(6):769-770. PubMed ID: 38587480
[TBL] [Abstract][Full Text] [Related]
3. Variations in Receipt of Curative-Intent Surgery for Early-Stage Non-Small Cell Lung Cancer (NSCLC) by State.
Sineshaw HM; Wu XC; Flanders WD; Osarogiagbon RU; Jemal A
J Thorac Oncol; 2016 Jun; 11(6):880-9. PubMed ID: 26980472
[TBL] [Abstract][Full Text] [Related]
4. The management of stage I Non-Small cell lung cancer (NSCLC) in Ontario: A Population-Based study of patterns of care and Stereotactic Ablative Body radiotherapy (SABR) utilization from 2010 to 2019.
Ashworth A; Kong W; Owen T; Hanna TP; Brundage M
Radiother Oncol; 2024 May; 194():110153. PubMed ID: 38364940
[TBL] [Abstract][Full Text] [Related]
5. Comparison of Treatment Outcomes Between Thoracoscopic Surgery and Stereotactic Body Radiotherapy for Early-Stage Non-Small Cell Lung Cancer.
Tian Q; Zhao X; Zhang C; Tian N; Bian H
Technol Cancer Res Treat; 2024; 23():15330338231219369. PubMed ID: 38378004
[No Abstract] [Full Text] [Related]
6. Decision Regret among Patients with Early-stage Lung Cancer Undergoing Radiation Therapy or Surgical Resection.
Sullivan DR; Wisnivesky JP; Nugent SM; Stone K; Farris MK; Kern JA; Swanson S; Smith CB; Rosenzweig K; Slatore CG
Clin Oncol (R Coll Radiol); 2023 Jun; 35(6):e352-e361. PubMed ID: 37031075
[TBL] [Abstract][Full Text] [Related]
7. Is surgery indicated for elderly patients with early stage nonsmall cell lung cancer, in the era of stereotactic body radiotherapy?
Nguyen NP; Godinez J; Shen W; Vinh-Hung V; Gorobets H; Thariat J; Ampil F; Vock J; Karlsson U; Chi A;
Medicine (Baltimore); 2016 Oct; 95(43):e5212. PubMed ID: 27787380
[TBL] [Abstract][Full Text] [Related]
8. LINAC-based SBRT in treating early-stage NSCLC patients-single institution experience and survival data analysis.
Kovács Á; Trási K; Barabás M; Gál K; Csiki E; Sipos D; Papp J; Simon M
Pathol Oncol Res; 2024; 30():1611589. PubMed ID: 38414671
[No Abstract] [Full Text] [Related]
9. Surveillance Practice Patterns after Curative Intent Therapy for Stage I Non-Small-Cell Lung Cancer in the Medicare Population.
Erb CT; Su KW; Soulos PR; Tanoue LT; Gross CP
Lung Cancer; 2016 Sep; 99():200-7. PubMed ID: 27565940
[TBL] [Abstract][Full Text] [Related]
10. Increased Utilization of Stereotactic Body Radiotherapy is Associated with Decreased Disparities and Improved Survival for Early-Stage NSCLC.
Ganesh A; Korpics M; Pasquinelli M; Feldman L; Spiotto M; Koshy M
Clin Lung Cancer; 2023 Jan; 24(1):60-71. PubMed ID: 36289032
[TBL] [Abstract][Full Text] [Related]
11. Racial disparities in staging, treatment, and mortality in non-small cell lung cancer.
Duncan FC; Al Nasrallah N; Nephew L; Han Y; Killion A; Liu H; Al-Hader A; Sears CR
Transl Lung Cancer Res; 2024 Jan; 13(1):76-94. PubMed ID: 38405005
[TBL] [Abstract][Full Text] [Related]
12. Examining the role of access to care: Racial/ethnic differences in receipt of resection for early-stage non-small cell lung cancer among integrated system members and non-members.
Check DK; Albers KB; Uppal KM; Suga JM; Adams AS; Habel LA; Quesenberry CP; Sakoda LC
Lung Cancer; 2018 Nov; 125():51-56. PubMed ID: 30429038
[TBL] [Abstract][Full Text] [Related]
13. "It wasn't as bad as I thought it would be": a qualitative study of early stage non-small cell lung cancer patients after treatment.
Golden SE; Thomas CR; Deffebach ME; Sukumar MS; Schipper PH; Tieu BH; Kee AY; Tsen AC; Slatore CG;
BMC Res Notes; 2017 Nov; 10(1):642. PubMed ID: 29187237
[TBL] [Abstract][Full Text] [Related]
14. Impact of Pretreatment Weight Loss on Radiotherapy Utilization and Clinical Outcomes in Non-Small Cell Lung Cancer.
Alvarez CM; Aliru M; Gannavarapu BS; Song T; Gilmore LA; Olaechea S; Gomez DR; Ahn C; Infante RE; Iyengar P
Am J Clin Oncol; 2024 Feb; 47(2):49-55. PubMed ID: 38011024
[TBL] [Abstract][Full Text] [Related]
15. Racial disparities in the use of SBRT for treating early-stage lung cancer.
Corso CD; Park HS; Kim AW; Yu JB; Husain Z; Decker RH
Lung Cancer; 2015 Aug; 89(2):133-8. PubMed ID: 26051446
[TBL] [Abstract][Full Text] [Related]
16. Adoption of Stereotactic Body Radiotherapy for Stage IA Non-Small Cell Lung Cancer Across the United States.
Holmes JA; Zagar TM; Chen RC
JNCI Cancer Spectr; 2017 Sep; 1(1):pkx003. PubMed ID: 31360829
[TBL] [Abstract][Full Text] [Related]
17. Temporal Trends of Health Disparity in the Utilization of Curative-Intent Treatments for Hepatocellular Carcinoma- Are we making progress?
Agudile EP; Vega EA; Salirrosas O; Agudile UM; Chirban AM; Lathan C; Sorescu GP; Odisio BC; Panettieri E; Conrad C
J Gastrointest Surg; 2024 May; ():. PubMed ID: 38754809
[TBL] [Abstract][Full Text] [Related]
18. Safety-net burden hospitals and likelihood of curative-intent surgery for non-small cell lung cancer.
Virgo KS; Little AG; Fedewa SA; Chen AY; Flanders WD; Ward EM
J Am Coll Surg; 2011 Nov; 213(5):633-43. PubMed ID: 21907598
[TBL] [Abstract][Full Text] [Related]
19. Racial and socioeconomic disparities in the use of stereotactic body radiotherapy for treating non-small cell lung cancer: a narrative review.
Lin Y; Mak KS
J Thorac Dis; 2021 Jun; 13(6):3764-3771. PubMed ID: 34277068
[TBL] [Abstract][Full Text] [Related]
20. Treatment of stage I and II non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.
Howington JA; Blum MG; Chang AC; Balekian AA; Murthy SC
Chest; 2013 May; 143(5 Suppl):e278S-e313S. PubMed ID: 23649443
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
